Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist that signals the brain to decrease appetite and increase feelings of fullness, leading to substantial weight reduction in clinical trials. The medication works by mimicking a natural hormone that regulates blood sugar and hunger signals. PlexusDx provides access to compounded semaglutide injections through licensed 503A pharmacies, making this treatment available without insurance across all states.

How Semaglutide Triggers Weight Loss in the Body

Semaglutide binds to GLP-1 receptors found throughout the brain, pancreas, and digestive system. This activation slows how quickly food moves from the stomach to the intestines, which keeps patients feeling satisfied longer after eating. The medication also directly signals the hypothalamus, the brain region controlling hunger and satiety, reducing the desire to eat and snack between meals.

The drug affects multiple hunger-related pathways simultaneously. It decreases appetite-stimulating signals while boosting satiety hormones, creating a dual effect that makes calorie restriction feel more manageable. Patients typically report feeling full on smaller portion sizes within the first few weeks of treatment, which removes the constant mental battle many face during weight loss attempts.

Clinical Trial Data: Real Weight Loss Results

Randomized controlled trials demonstrate that semaglutide produces weight reductions of 15-22% of baseline body weight over 68 weeks when combined with diet and exercise. In the STEP trials, patients receiving semaglutide lost an average of 10-15 kg more than those taking placebo. These findings represent the most significant pharmacologic weight loss outcomes documented in recent medical literature.

The weight loss is sustained as long as patients remain on treatment. Studies tracking participants for over two years show continued reductions and weight maintenance when the medication is continued. Discontinuing semaglutide typically results in gradual weight regain, underscoring that this is a long-term therapy rather than a short-term fix.

Factors That Influence Individual Weight Loss Response

Not every patient experiences identical weight loss outcomes, even at the same dose. Genetic variations in GLP-1 receptor sensitivity, appetite regulation genes, and metabolic pathways create individual differences in medication response. PlexusDx Precision Peptide Genetic Test identifies key variants including GLP1R rs6923761 and MC4R rs17782313 that predict how effectively your body will respond to GLP-1 therapy.

Age, baseline body weight, insulin resistance status, and concurrent medication use also shape results. Patients with severe insulin resistance may require higher doses for comparable weight loss. Combining semaglutide with consistent physical activity and dietary changes produces superior outcomes compared to medication alone, with studies showing 5-10% additional weight reduction from lifestyle interventions.

Accessing Compounded Semaglutide Through PlexusDx

PlexusDx compounded semaglutide injections start at $149 per month, with your dose able to increase as needed while your price remains fixed. The medication is prepared by licensed 503A compounding pharmacies meeting FDA standards for sterility and potency. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization delays.

HSA and FSA accounts are eligible for PlexusDx semaglutide, providing tax-advantaged payment options. Patients can add the Precision Peptide Genetic Test for $99 after their first month to optimize treatment based on personal genetic predispositions. Monthly refills ship directly to patients or healthcare providers, with clinical support available throughout the treatment journey.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I realistically expect to lose with semaglutide?

Clinical trials show average weight loss of 15-22% of body weight over 68 weeks, typically 10-15 kg more than placebo. Individual results vary based on genetics, lifestyle adherence, and baseline health status. PlexusDx offers the Precision Peptide Genetic Test to help predict your personal response potential.

How does semaglutide compare to other weight loss medications?

Semaglutide produces greater weight loss than older medications like phentermine or naltrexone-bupropion combinations. PlexusDx also offers tirzepatide, a dual GIP/GLP-1 agonist showing 20-25% weight loss in trials, providing options to match individual needs and genetic profiles.

What is PlexusDx semaglutide pricing and how does dosing work?

PlexusDx compounded semaglutide injections start at $149 per month regardless of dose strength. Your dose can increase as clinically indicated, but your monthly price stays the same—no hidden tier jumps. Service is available in all 50 states without insurance.

Are there side effects or safety concerns with semaglutide?

Common side effects include nausea, vomiting, diarrhea, and constipation, typically mild and improving over weeks as the body adjusts. Rare but serious risks include pancreatitis and thyroid issues; patients with personal or family thyroid cancer history should not use GLP-1 drugs. PlexusDx recommends baseline bloodwork and ongoing monitoring through licensed providers.

Can the Precision Peptide Genetic Test predict if semaglutide will work for me?

Yes. The Precision Peptide Genetic Test maps 14 pathways and 150+ genetic insights, including GLP1R and MC4R variants that directly influence semaglutide efficacy. At $99 after your first month, this test helps PlexusDx tailor your therapy and explain why you may respond differently than others.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves